My Cart
Your Cart 0

    Your cart is empty.

  • Total (Amount) ₹0.00
Exam Details

Biotechnology (BT) 2013

Review the key details, then start the test when you are ready. You can also open the full package to see related papers.

Questions 65
Duration 180 mins
Package Biotechnology (BT) - Previous Year Papers

Paper pattern & analysis

Filter this paper by subject, topic or subtopic. Every graph updates from the selected questions.

Explore previous papers
Showing all 65 questions in this paper.

Subject distribution

No subject classification is available.

Topic distribution

No topic classification is available.

Subtopic distribution

No subtopic classification is available.

Difficulty distribution

Easy 55 84.6%
Hard 10 15.4%

Question type distribution

Multiple Choices 55 84.6%
Fill in the blanks 10 15.4%

Instructions

Biotechnology (BT) 2013 – Instructions
  • Total number of questions: 65
  • 30 questions carry one mark each
  • 35 questions carry two marks each
  • Negative marking: 1/3 of the marks allotted to the question
  • Use of calculator is allowed
  • This is a proctored examination
  • All other browser applications will be automatically closed
  • After three warnings, the examination window will close automatically

Syllabus

Full Syllabus

Sample questions from this paper

Questions are selected across the paper subjects wherever the paper contains that variety.

1
2013 · Unclassified
Biotechnology (BT) 2013
Q.1 – Q.25 carry one mark each.

Under alkaline conditions, DNA is more stable than RNA because

A
RNA is a single stranded molecule
B
RNA has uracil in place of thymidine
C
RNA is susceptible to hydrolysis
2
2013 · Unclassified
Biotechnology (BT) 2013

Which one of the following modifications is common to both protein and DNA?

A
SUMOylation
B
Nitrosylation
C
Methylation
D
Ubiquitination
3
2013 · Unclassified
Biotechnology (BT) 2013

Protein A, which has strong affinity to Fc region of immunoglobulin, is extracted from

A
Saccharomyces cerevisiae
B
Staphylococcus aureus
C
Streptococcus pyogenes
D
Streptococcus sanguis
4
2013 · Unclassified
Biotechnology (BT) 2013

The first humanized monoclonal antibody approved for the treatment of breast cancers

A
Rituximab
B
Cetuximab
C
Bevacizumab
D
Herceptin
5
2013 · Unclassified
Biotechnology (BT) 2013

Which one of the following aminoacids in proteins does NOT undergo phosphorylation?

A
Ser
B
Thr
C
Pro
D
Tyr
6
2013 · Unclassified
Biotechnology (BT) 2013

The role of an adjuvant is to

A
prolong the persistence of antigen
B
cross link the antigen
C
increase the size of antigen
D
avoid inflammation